The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers

Abstract Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, lacking effective therapy. Many TNBCs show remarkable response to carboplatin-based chemotherapy, but often develop resistance over time. With increasing use of carboplatin in the clinic, there is a pressing...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Stijn Moens, Peihua Zhao, Maria Francesca Baietti, Oliviero Marinelli, Delphi Van Haver, Francis Impens, Giuseppe Floris, Elisabetta Marangoni, Patrick Neven, Daniela Annibali, Anna A. Sablina, Frédéric Amant
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/23a5f34fef334ff789f85c69f707a9be
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires